MedPath

Comparison of microneedling with Tranexamic acid and PRP in treatment of Melasma

Phase 2
Conditions
Melasma.
Other disorders of pigmentation
Registration Number
IRCT20221025056287N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
23
Inclusion Criteria

18-50 years old women with Melasma
Symmetrical and bilateral facial Melasma

Exclusion Criteria

Pregnant women
Breastfeeding mothers
Use of anticoagulants and anticonvulsants
Being allergic to the study drugs and topical lidocaine
History of Melasma treatment during the past month
Active Herpes simplex lesions on the face
Facial warts
Any history of coagulation disorders and thrombotic problems

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Melasma measuring index (MASI SCORE). Timepoint: At the beginning of the study, the second and third sessions and 3 weeks after the completion of treatment sessions. Method of measurement: Taking photo of the face with camera.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath